Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials

Müller-Wieland D, McGuire DK, Lincoff AM, Buse JB, Mann JF, Inzucchi SE, Pop-Busui R, Mulvagh SL, Emerson SS, Poulter NR, Deanfield JE, Marx N (2026)

Publication Type: Journal article

Publication year: 2026

Journal

Diabetes Obesity & Metabolism Wiley-Blackwell

DOI: 10.1111/dom.70752

Involved external institutions

Universitätsklinikum Aachen (UKA)

Germany (DE) University of Texas Southwestern Medical Center (UT Southwestern)

United States (USA) (US) Yale University

United States (USA) (US) Oregon Health and Science University (OSHU)

United States (USA) (US) Dalhousie University

Canada (CA) University of Washington

United States (USA) (US) Imperial College London / The Imperial College of Science, Technology and Medicine

United Kingdom (GB) University College London (UCL)

United Kingdom (GB) Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM)

United States (USA) (US) University of North Carolina at Chapel Hill

United States (USA) (US) KfH Kuratorium für Dialyse und Nierentransplantation e.V.

Germany (DE)

How to cite

APA:

Müller-Wieland, D., McGuire, D.K., Lincoff, A.M., Buse, J.B., Mann, J.F., Inzucchi, S.E.,... Marx, N. (2026). Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials. Diabetes Obesity & Metabolism. https://doi.org/10.1111/dom.70752

MLA:

Müller-Wieland, Dirk, et al. "Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials." Diabetes Obesity & Metabolism (2026).

BibTeX: Download